1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Drug Discovery and Development

Drug Discovery & Development Sector: Latest Market Trends and Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Topics under Drug Discovery and Development

Global Drug Discovery and Development Industry

The global drug discovery and development industry (part of the wider pharmaceutical industry) involves the discovery and design of drugs through laboratory testing to treat disease and infection. With costs running high and few drugs making it to the market, drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.

One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process. The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015, according to Business Insights. Meanwhile, the global drug discovery technologies market is expected to be worth more than $32 billion by 2012, growing at an annual compound rate in excess of 8%.

The industry requires heavy investment with no guarantee of results, including under 1% of discoveries going on to be approved by the US Food and Drug Administration. The process itself can take between 12 and 20 years, and cost over the $1.2 billion mark, reports the Alfred Mann Foundation for Biomedical Engineering.

Leading Market Segments

It is estimated that high throughput screening will be worth $12 billion by 2012, showing over 7% growth in the preceding five years.

Bioanalytical instruments have a forecast worth of $10.5 billion in 2012, demonstrating growth in excess of 9%. It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012. Business Insights estimates the electronic data capture market for clinical trials will pass the $1 billion mark in 2016 at 13% annual growth.

Process: Drug Testing and Development

The steps involved in drug discovery begin with the identification of targets, which are genetic or cellular chemicals that influence disease. Once the target has been isolated, the compounds that may work best on them can in turn be determined. Next, the chosen target’s capacity to act on diseased cells is observed before compounds necessary to create a drug are determined, along with the drug target’s response to the compound. In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.

Once a drug has been designed, it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells. The drug also undergoes toxicology testing to determine any possible harm to humans. In the clinical phase, drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug. Research compiled throughout the process is submitted to the relevant authority as the company awaits approval; this part of the process can last up to two years.

Contract Research Organization (CRO) Market Value (2005 - 2010) 

Read more »


You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+1 646 893 5945

5 Reports
Company, Forecast, Product Initiative
9 Statistics
Company, Finance, Market Size
140 Reports
Company Financials, Company, Product Initiative
58 Statistics
Company, Finance, Company Financials
7 Reports
Regulation, Product Initiative, Forecast
23 Statistics
Finance, Product Initiative, Company Financials
8 Reports
Company Financials, Market Size, Forecast
6 Statistics
Company, Finance, Market Size
3 Reports
Company Financials, Forecast, Company
2 Statistics
Company, Finance, Company Financials
20 Reports
Company Financials, Demand, Company
41 Statistics
Finance, Company Financials, Demand
3 Reports
Company, Product Initiative, Company Operations
Search in Drug Discovery And Development Industry (About 500 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Generic Drug, OTC, Pharmacy, Prescription Drug, Therapy

About 2200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 297 - $ 19129)

Humanized Mouse Model Market by Type, Application & End User(Pharmaceutical & Biotech Companies, CRO - Global Forecast to 2021

Humanized Mouse Model Market: Global Forecast until 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The humanized mouse model market is projected to reach USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years (2016 to 2021). Growing adoption of personalized ...

Rat Model Market: Forecast until 2021 $ 5650 January 2017

Clinical Trial Imaging Market: Global Forecast until 20 ... $ 5650 December 2016

Contract Research Organizations Services Market: Global ... $ 5650 October 2016

Clinical Trial Management System Market: Global Forecas ... $ 5650 August 2016

Drug Discovery Services Market: Forecast until 2022 $ 5650 October 2017

eClinical Solutions Market: Global Forecast until 2022 $ 5650 April 2017

Mice Model Market: Global Forecast until 2021 $ 5650 February 2017

Clinical Research in Anemia in Chronic Kidney Disease ( ... $ 2500 September 2016

Clinical Research in Parkinson's Disease in H2, 2016 $ 2500 September 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.